Mobile Medication Adherence Platform for Buprenorphine-Naloxone During Treatment of Opioid Use Disorder: Phase I Study

Condition:   Opioid-use Disorder Intervention:   Behavioral: Reminders messages to improve adherence. Sponsors:   Washington State University;   National Institute on Drug Abuse (NIDA) Not yet recruiting

Source: ClinicalTrials.gov - December 7, 2020 Category: Research Source Type: clinical trials